Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in OCGN — Ocugen, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$490,542
+$349,542 QoQ
Shares Held
320,617
+311.6% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 147 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. OCGN ranks #187 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in OCGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $490,542 320,617
2026-03-31 $141,000 77,901
2025-12-31 $5,401 4,001
2025-09-30 $1,744 1,070
2025-06-30 $11,152 11,497
2025-03-31 $103,963 147,257
2024-12-31 $114,127 141,773
2024-09-30 $86,142 86,838
2024-06-30 $139,578 90,051
2024-03-31 $11,537 7,035
2023-12-31 $6,240 10,853
2023-09-30 $4,273 10,684
2023-06-30 $5,516 10,161
2023-03-31 $43,094 50,521
2022-12-31 $11,050 8,500
2022-09-30 $44,608 25,061
2022-06-30 $65,861 29,014
2022-03-31 $435,447 131,954
2021-12-31 $851,404 187,122
2021-09-30 $1,153,774 160,693
2021-06-30 $122,183 15,216
2021-03-31 $40,188 5,919
2020-12-31 $10,165 5,555
2020-09-30 $256 828
2020-06-30 $47 216
2020-03-31 $60 214